骨科翻修手术中骨水泥表面万古霉素涂层:提高局部抗生素浓度的安全技术
该纵向病例系列研究分析了因假体周围感染行翻修手术(一期或二期置换)并接受骨水泥表面万古霉素涂层(SVC)的患者,术后第1至5天检测引流液局部和血液全身万古霉素浓度及术前术后血清肌酐。结果显示再植入组术后第1天局部万古霉素中位浓度最高达546.8 μg/mL, spacer组为408.7 μg/mL,血清浓度均低,未观察到过敏反应或其他副作用。作者认为SVC是提高局部万古霉素浓度而不引起全身副作用的安全有效技术。
要点
- 再植入组术后第1天局部万古霉素中位浓度为546.8 μg/mL(范围44.4-1485 μg/mL)。
- spacer组术后第1天局部万古霉素中位浓度为408.7 μg/mL(范围24.7-1650 μg/mL)。
- 两组术后第1天血清万古霉素中位浓度均低,术后第2至5天均低于2.0 μg/mL,未观察到过敏反应或其他副作用。
核心结论
- 骨水泥表面万古霉素涂层是提高局部万古霉素浓度而不导致全身副作用的安全有效技术。
研究设计与样本
- 纵向病例系列研究,回顾性分析因假体周围感染行翻修手术(一期或二期置换)并接受骨水泥表面万古霉素涂层治疗的患者数据。
主要发现
- 再植入组术后第1天局部万古霉素中位浓度最高,为546.8 μg/mL(范围44.4-1485 μg/mL)。
- spacer组术后第1天局部万古霉素中位浓度最高,为408.7 μg/mL(范围24.7-1650 μg/mL)。
- 再植入组术后第1天血清万古霉素中位浓度为4.4 μg/mL(范围<2.0-11.7 μg/mL),spacer组为<2.0 μg/mL(范围<2.0-3.9 μg/mL)。
- 两组术后第2至5天血清万古霉素中位浓度均低于2.0 μg/mL(范围<2.0-7.5 μg/mL)。
- 未观察到对骨水泥表面万古霉素涂层的过敏反应或其他副作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of antibiotic-loaded cement has become a well-accepted method to develop high local antibiotic concentrations in revision surgery of infected arthroplasty. A new surgical technique has been established to further increase the local antibiotic concentration and thereby minimizes the risk of reinfection. Our study aim was to investigate the safety of additional superficial vancomycin coating (SVC) by analyzing postoperative joint and serum vancomycin concentrations, as well as the creatinine levels of patients with orthopedic revision surgery. METHODS: A longitudinal case series was performed by reviewing collected data of patients who were treated by SVC during revision surgery (1- or 2-stage exchange) because of prosthetic joint infections. Vancomycin levels were obtained, local from drains and systemic from blood samples, on postoperative days 1 to 5. Furthermore, preoperative and postoperative serum creatinine levels were analyzed. RESULTS: Highest median local vancomycin levels were documented on postoperative day 1 with 546.8 μg/mL (range, 44.4-1485 μg/mL) in the reimplantation group and 408.7 μg/mL (range, 24.7-1650 μg/mL) in the spacer group. Median serum vancomycin level was 4.4 μg/mL (range, <2.0-11.7 μg/mL) on the first postoperative day in the reimplantation group and <2.0 μg/mL (range, <2.0-3.9 μg/mL) in the spacer group, and lower than 2.0 μg/mL (range, <2.0-7.5 μg/mL) from postoperative day 2 to 5 in both groups. Neither an anaphylactic reaction nor other side effects to SVC were observed. CONCLUSION: Our data showed that SVC of bone cement is an effective technique to enhance local concentrations of vancomycin without leading to systemic side effects.
引用
- Amerstorfer F, Fischerauer S, Sadoghi P, et al. Superficial Vancomycin Coating of Bone Cement in Orthopedic Revision Surgery: A Safe Technique to Enhance Local Antibiotic Concentrations. J Arthroplasty. 2016. PMID: 28111125. doi:10.1016/j.arth.2016.11.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。